Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism

BACKGROUND: Lowering the dose of desoxycorticosterone pivalate (DOCP) for the treatment of dogs with primary hypoadrenocorticism (PH) decreases costs and could lead to increased owner motivation to treat their affected dogs. OBJECTIVE: To evaluate the efficacy of a low‐dose DOCP treatment protocol i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieber‐Ruckstuhl, Nadia S., Reusch, Claudia E., Hofer‐Inteeworn, Nathalie, Kuemmerle‐Fraune, Claudia, Müller, Claudia, Hofmann‐Lehmann, Regina, Boretti, Felicitas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524388/
https://www.ncbi.nlm.nih.gov/pubmed/30865322
http://dx.doi.org/10.1111/jvim.15475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524388/
https://www.ncbi.nlm.nih.gov/pubmed/30865322
http://dx.doi.org/10.1111/jvim.15475

Ejemplares similares